We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$75.6B
AUM Growth
+$332M
(+0.44%)
Cap. Flow
-$1.48B
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
9.2%
Holding
2,306
New
139
Increased
928
Reduced
1,013
Closed
118
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$234M |
| 2 |
eBay
EBAY
|
+$223M |
| 3 |
Walt Disney
DIS
|
+$189M |
| 4 |
Humana
HUM
|
+$184M |
| 5 |
DXC Technology
DXC
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$236M |
| 2 |
Citizens Financial Group
CFG
|
+$157M |
| 3 |
Applied Materials
AMAT
|
+$156M |
| 4 |
Huntsman Corp
HUN
|
+$154M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.77% |
| 2 | Technology | 16.07% |
| 3 | Industrials | 14.94% |
| 4 | Consumer Discretionary | 12.29% |
| 5 | Healthcare | 11.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KBAL
1551
DELISTED
Kimball International
KBAL
| $1.36M | ﹤0.01% |
81,626
+13,246
| +19% | +$230K |
|
|
ESPR
1552
DELISTED
Esperion Therapeutics
ESPR
| $1.36M | ﹤0.01% |
+29,407
| New | +$1.08M |
|
1553
IAMGOLD
IAG
$9.18B
| $1.35M | ﹤0.01% |
262,333
+235,373
| +873% | +$1.06M |
|
|
LCI
1554
DELISTED
Lannett Company, Inc.
LCI
| $1.35M | ﹤0.01% |
16,541
+6,902
| +72% | +$601K |
|
|
MR
1555
DELISTED
Montage Resources Corporation Common Stock
MR
| $1.35M | ﹤0.01% |
31,463
-36,237
| -54% | -$1.27M |
|
1556
DXP Enterprises
DXPE
$2.61B
| $1.35M | ﹤0.01% |
39,073
+30,993
| +384% | +$1.13M |
|
1557
Inogen
INGN
$178M
| $1.35M | ﹤0.01% |
14,122
| – | – |
|
|
EBSB
1558
DELISTED
Meridian Bancorp, Inc.
EBSB
| $1.35M | ﹤0.01% |
79,637
+41,249
| +107% | +$712K |
|
|
SHOE
1559
Shoe Station Group
SHOE
$424M
| $1.34M | ﹤0.01% |
128,364
-21,472
| -14% | -$237K |
|
1560
Adeia
ADEA
$3.3B
| $1.33M | ﹤0.01% |
169,034
-66,997
| -28% | -$565K |
|
|
CBL
1561
DELISTED
CBL& Associates Properties, Inc.
CBL
| $1.33M | ﹤0.01% |
158,076
-49,584
| -24% | -$426K |
|
|
MRC
1562
DELISTED
MRC Global
MRC
| $1.32M | ﹤0.01% |
80,218
-232,637
| -74% | -$4.26M |
|
1563
Community Bank
CBU
$3.48B
| $1.32M | ﹤0.01% |
23,713
-1,046
| -4% | -$57.9K |
|
1564
Marcus Corp
MCS
$949M
| $1.32M | ﹤0.01% |
43,594
+8,595
| +25% | +$278K |
|
|
LOXO
1565
DELISTED
Loxo Oncology, Inc
LOXO
| $1.31M | ﹤0.01% |
16,397
+8,280
| +102% | +$459K |
|
|
ORIT
1566
DELISTED
Oritani Financial Corp. New
ORIT
| $1.31M | ﹤0.01% |
76,622
+5,836
| +8% | +$98.5K |
|
|
NSA
1567
DELISTED
National Storage Affiliates Trust
NSA
| $1.3M | ﹤0.01% |
56,345
-47,104
| -46% | -$1.13M |
|
|
IXYS
1568
DELISTED
IXYS Corp
IXYS
| $1.3M | ﹤0.01% |
79,019
-25,015
| -24% | -$374K |
|
|
ALR
1569
DELISTED
Alere Inc
ALR
| $1.3M | ﹤0.01% |
25,892
| – | – |
|
1570
ICU Medical
ICUI
$4.16B
| $1.3M | ﹤0.01% |
7,513
+739
| +11% | +$119K |
|
1571
Colliers International
CIGI
$5.17B
| $1.29M | ﹤0.01% |
22,900
| – | – |
|
1572
Arthur J. Gallagher & Co
AJG
$64.3B
| $1.29M | ﹤0.01% |
22,534
| – | – |
|
|
HEES
1573
DELISTED
H&E Equipment Services
HEES
| $1.28M | ﹤0.01% |
62,705
-26,037
| -29% | -$546K |
|
1574
Copart
CPRT
$26.8B
| $1.28M | ﹤0.01% |
160,880
-9,360
| -5% | -$71.7K |
|
1575
Power Integrations
POWI
$3.45B
| $1.28M | ﹤0.01% |
35,092
-12,092
| -26% | -$401K |
|
Similar funds
VGA
AQR Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, AQR Capital Management held 2,306 positions worth $75.6B, up 0.44% from $75.2B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
AQR Capital Management's Q2 2017 filing shows 139 new, 928 increased, 1,013 reduced and 118 closed positions. Its largest new stake was DXC Technology: 2,594,054 shares worth $172M. The largest sale was Wells Fargo, an estimated $236M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- AQR Capital Management's largest Q2 2017 buy was DXC Technology: 2,594,054 shares worth $172M.
- AQR Capital Management added most to Gilead Sciences in Q2 2017, an estimated $234M increase.
- AQR Capital Management's biggest Q2 2017 reduction was Wells Fargo, cutting an estimated $236M.
- AQR Capital Management fully exited Computer Sciences in Q2 2017, selling an estimated $77.8M.
- AQR Capital Management's ten largest holdings make up 9.2% of its $75.6B portfolio in Q2 2017.
- AQR Capital Management opened 139 new positions and closed 118 in Q2 2017.
- AQR Capital Management's portfolio value rose 0.44% quarter-over-quarter to $75.6B.
Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.